Teva Pharmaceuticals Marc A. Goshko Memorial Grant Program
The Teva Pharmaceuticals Marc A. Goshko Memorial Grant Program is administered by the ACS Office of Research Grants with funding provided by Teva Pharmaceuticals. The program is a philanthropic grant program that supports academic researchers ("Teva Scholars") in the fields of organic and medicinal chemistry named in honor of Marc A. Goshko who was instrumental in initiating it.
Amount: $100,000 per year for 3 years
Number of awards: 1
Award period: September 1, 2018 to August 31, 2021
An applicant must be a recently-tenured faculty member of a PhD-granting department in the United States. Read more about Eligibility, Terms, and Conditions for Teva Pharmaceuticals Marc A. Goshko Memorial Grant Program.
Research Area and Evaluation Criteria
Applications for the Teva Pharmaceuticals Scholars grants must propose research in the area of organic chemistry, with potential or direct connections with medicinal or pharmaceutical chemistry, such that the successful results would be of potential practical benefit to the discovery of organic compounds useful as human medicines. Proposals are evaluated on: a) scientific merit, creativity and novelty; and b) addressing unexplored fields in organic and/or medicinal chemistry. General aspects of research proposals will also be considered, such as: Is the project achievable within the time frame? Are the personnel and facilities adequate? Does the applicant consider and address potential problems?
The following budget restrictions apply:
No institutional overhead charges, nor facilities and adminsistrative charges will be charged to the grant nor will any be provided by ACS-Teva.
Applications will include a budget in the amount of $100,000 for each of three years (Total = $300,000) with the following categories: personnel (see below); reagents and expendables; permanent equipment; travel. A brief budget explanation should be part of the proposal; budget considerations may be part of the evaluation of the proposal.
A maximum of $10,000 per year may be used to support the principal investigator’s salary, including benefits. Postdoctoral fellows, research associates, technicians, graduate students (stipend and/or tuition), and/or undergraduate students may be supported through the grant, at levels commensurate with the grantee’s department or academic unit.
A maximum of $5,000 per year may be used for travel, including travel to conferences or symposia, or to collaborating laboratories. Travel to present research results must be budgeted for the third year; (see below).
At the end of each grant year, the grantee will submit a financial report and a scientific progress report; (see below). Of the support given, funds remaining at the end of each grant year may be carried forward into the next year in the same budget category.
Each grant recipient is required to submit annual scientific progress and financial reports to the ACS Office of Research Grants. ACS shall, in its sole discretion and consistent with its standard practices, determine whether the grant recipient is meeting the goals and objectives appropriately.
Each grant recipient is required to present a lecture during or promptly following the grant period at a time and place to be agreed upon by the grant recipient and the ACS. Recipients’ travel costs in connection with the lecture should be budgeted in travel for the third year.
2015 Teva Scholars to Present Research
The 2015 Teva Scholars presented the results of their funded research at a symposium sponsored by the ACS Division of Organic Chemistry at the ACS National Meeting in Boston, MA. The symposium “Biologically Related Molecules and Processes” was held on August 20, 2018.
Teva Pharmaceuticals Scholar (2018-2021)
Past TEVA Grantees
We are not accepting new applications at this time. Please check back in the Winter of 2020 for information on the next proposal submission window.
Teva Pharmaceuticals Scholars in the News
Dr. Tehshik P. Yoon Wins Organic Letters Outstanding Publication of the Year Award Lectureship for 2018. Read more